Skip to main content
OpenTrials

Clinical trial condition

Hereditary Sensory and Autonomic Neuropathies

Explore clinical trials studying Hereditary Sensory and Autonomic Neuropathies. Study availability and eligibility vary by location and protocol.

116 public trials 25 recruiting studies
Refine in advanced search Browse all conditions

Hereditary Sensory and Autonomic Neuropathies trial results

Completed

Safety, Tolerability & Potential Anti-cancer Activity of Increasing Doses of AZD5363 in Different Treatment Schedules

NCT01226316

Conditions
AKT1, Adnexal Diseases, Advanced Solid Malignancy, +46 more
Locations
  • Research Site Los Angeles, California, United States
  • Research Site Stanford, California, United States
  • Research Site West Hollywood, California, United States
  • Research Site Aurora, Colorado, United States
View all 34 locations
View Trial Details
Completed

Dose Escalation of RMC-5552 Monotherapy in Relapsed/Refractory Solid Tumors

NCT04774952

Conditions
Adnexal Diseases, Bronchial Diseases, Bronchial Neoplasms, +63 more
Locations
  • UC Irvine - Chao Family Comprehensive Cancer Center Irvine, California, United States
  • UC Davis Comprehensive Cancer Center Sacramento, California, United States
  • UC San Francisco - Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States
  • Moffitt Cancer Center Tampa, Florida, United States
View Trial Details
Completed

A Study of INCB050465 in Relapsed or Refractory Follicular Lymphoma

NCT03126019

Conditions
Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, +18 more
Locations
  • Arizona Oncology Associates - Biltmore Cancer Center Phoenix, Arizona, United States
  • Beverly Hills Cancer Center Beverly Hills, California, United States
  • Synergy Hematology and Oncology Medical Associates Los Angeles, California, United States
  • St. Joseph Heritage Healthcare Santa Rosa, California, United States
View all 83 locations
View Trial Details
Completed

ATRi Transition Rollover Study

NCT03309150

Conditions
Advanced Stage Solid Tumors, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +9 more
Locations
  • Royal Marsden NHS Foundation Trust Sutton, United Kingdom
View Trial Details
Completed

Berzosertib Human Mass Balance Study (DDRiver Solid Tumors 208)

NCT05246111

Conditions
Advanced Solid Tumor, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +9 more
Locations
  • Magyar Honvédség Egészségügyi Központ, Podmaniczky utcai telephely, Onkológiai Osztály Budapest, Hungary
  • PRA Magyarország Kft. Fázis I-es Klinikai Farmakológiai Vizsgálóhely Budapest, Hungary
View Trial Details
Completed

Berzosertib + Topotecan in Relapsed Platinum-Resistant Small-Cell Lung Cancer (DDRiver SCLC 250)

NCT04768296

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Congenital Abnormalities, +19 more
Locations
  • Providence Medical Foundation Santa Rosa, California, United States
  • St Joseph Heritage Healthcare Santa Rosa, California, United States
  • Cotton-O'Neil Clinical Research Center, Hematology and Oncology Topeka, Kansas, United States
  • National Cancer Institute Bethesda, Maryland, United States
View all 51 locations
View Trial Details
Completed

Study to Test How Well Patients With Advanced Solid Tumors Respond to Treatment With the Elimusertib in Combination With Pembrolizumab, to Find the Optimal Dose for Patients, How the Drug is Tolerated and the Way the Body Absorbs, Distributes and Discharges the Drug

NCT04095273

Conditions
Advanced Solid Tumors, Ataxia, Ataxia Telangiectasia, +28 more
Locations
  • Stanford University Palo Alto, California, United States
  • Yale Cancer Center New Haven, Connecticut, United States
  • Johns Hopkins Hospital/Health System Baltimore, Maryland, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
View all 16 locations
View Trial Details

Related conditions